← Leaderboards
Randy Scott Rector
University Of Missouri-Columbia
$3,318,467
Attributed
$8,686,922
Total exposure
8
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.5M · FY2008–25$2M$1.5M$1M$500K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$8,686,922 · 5
VA$0 · 3
By mechanism
R01$7,030,019 · 3
U01$1,569,053 · 1
F32$87,850 · 1
I01$0 · 1
IK2$0 · 1
IK6$0 · 1
Top collaborators
- Jamal A Ibdah6 shared
- Elizabeth Jane Parks6 shared
- Bysani Chandrasekar4 shared
- Frank W Booth3 shared
- Guangfu Li3 shared
- Kevin Finnbar Staveleyo'Carroll3 shared
- John P Thyfault3 shared
Most similar at University Of Missouri-Columbia
Same institution · by research overlap
- Dennis B Lubahn$3,325,524
- Frank W Booth$4,955,173
- Cristine L Heaps$4,794,393
- Elizabeth C Bryda$14,168,154
- Elmer M Price$2,165,296
Others in their field
Top investigators on “Hepatic”
- Judith S. Currier · University Of California Los Angeles$284,891,719
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$200,049,347
- Constance Ann Benson · University Of California, San Diego$185,061,530
- Daniel R Kuritzkes · Brigham And Women'S Hospital$174,515,698
- Michael David Hughes · Harvard University D/B/A Harvard School Of Public Health$146,381,332
- Sharon A Nachman · Johns Hopkins University$135,132,510
Research focus
HepaticLiverMediatingMolecularLiver DiseasesObesityNon-Alcoholic Fatty Liver DiseaseLinkMitochondriaNonalcoholic SteatohepatitisProductionIn VitroPrevalenceLiver MitochondriaLipidsIn VivoInflammationAffectMortalityMitochondrial DysfunctionInsightFibrosisExerciseTherapeutic Target
Grant awards (30)
RECK regulation of NASH and fibrosis$551,909
R01 · FY2025 · DK · contact PI
BLRD Research Career Scientist Award Application$0
IK6 · FY2025 · VA · contact PI
Hepatic eNOS in the regulation of NASH$0
I01 · FY2025 · VA · contact PI
RECK regulation of NASH and fibrosis$529,832
R01 · FY2024 · DK · contact PI
Mechanisms of gut microbiota/metabolite interface-mediated hepatic inflammation$397,590
R01 · FY2024 · DK
Hepatic eNOS in the regulation of NASH$0
I01 · FY2024 · VA · contact PI
RECK regulation of NASH and fibrosis$551,909
R01 · FY2023 · DK · contact PI
Mechanisms of gut microbiota/metabolite interface-mediated hepatic inflammation$394,466
R01 · FY2023 · DK
RECK regulation of NASH and fibrosis$551,909
R01 · FY2022 · DK · contact PI
Molecular Transducers of Physical Activity: Liver Adaptations Drive Brain Benefits$516,685
U01 · FY2022 · AG · contact PI
Mechanisms of gut microbiota/metabolite interface-mediated hepatic inflammation$400,000
R01 · FY2022 · DK
Nutrient Overload, Insulin Resistance, and Hepatic Mitochondrial Dysfunction$690,058
R01 · FY2021 · DK
Molecular Transducers of Physical Activity: Liver Adaptations Drive Brain Benefits$516,059
U01 · FY2021 · AG · contact PI
Nutrient Overload, Insulin Resistance, and Hepatic Mitochondrial Dysfunction$188,834
R01 · FY2021 · DK
Nutrient Overload, Insulin Resistance, and Hepatic Mitochondrial Dysfunction$692,311
R01 · FY2020 · DK
Molecular Transducers of Physical Activity: Liver Adaptations Drive Brain Benefits$536,309
U01 · FY2020 · AG · contact PI
Hepatic eNOS and Mitochondrial Function in NASH$0
I01 · FY2020 · VA · contact PI
Nutrient Overload, Insulin Resistance, and Hepatic Mitochondrial Dysfunction$689,516
R01 · FY2019 · DK
Hepatic eNOS and Mitochondrial Function in NASH$0
I01 · FY2019 · VA · contact PI
Nutrient overload, insulin resistance, and hepatic mitochondrial dysfunction$694,416
R01 · FY2018 · DK
Hepatic eNOS and Mitochondrial Function in NASH$0
I01 · FY2018 · VA · contact PI
Nutrient overload, insulin resistance, and hepatic mitochondrial dysfunction$697,269
R01 · FY2017 · DK
Hepatic eNOS and Mitochondrial Function in NASH$0
I01 · FY2017 · VA · contact PI
Hepatic Mitochondria and Insulin Resistance in Fatty Liver and Type 2 Diabetes$0
IK2 · FY2015 · VA · contact PI
Hepatic Mitochondria and Insulin Resistance in Fatty Liver and Type 2 Diabetes$0
IK2 · FY2014 · VA · contact PI
Hepatic Mitochondria and Insulin Resistance in Fatty Liver and Type 2 Diabetes$0
IK2 · FY2013 · VA · contact PI
Hepatic Mitochondria and Insulin Resistance in Fatty Liver and Type 2 Diabetes$0
IK2 · FY2012 · VA · contact PI
Hepatic Mitochondria and Insulin Resistance in Fatty Liver and Type 2 Diabetes$0
IK2 · FY2011 · VA · contact PI
Exercise, mitochondrial function, and fatty acid oxidation in fatty liver disease$41,024
F32 · FY2009 · DK · contact PI
Exercise, mitochondrial function, and fatty acid oxidation in fatty liver disease$46,826
F32 · FY2008 · DK · contact PI